BIOLASE, INC. Deferred Tax Assets, Valuation Allowance
BIOLASE, INC. had Deferred Tax Assets, Valuation Allowance of $35.81 million as of 2023-12-31, per its 10-K filed 2024-03-21.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2024-03-21
- 2023-12-31: Deferred Tax Assets, Valuation Allowance $35.81M.
- 2022-12-31: Deferred Tax Assets, Valuation Allowance $31.23M.
- 2021-12-31: Deferred Tax Assets, Valuation Allowance $27.26M; Deferred Tax Assets, Valuation Allowance as first filed $57.68M.
- 2020-12-31: Deferred Tax Assets, Valuation Allowance $52.16M; Deferred Tax Assets, Valuation Allowance as first filed $56.03M.
| Period end | Deferred Tax Assets, Valuation Allowance | Deferred Tax Assets, Valuation Allowance as first filed |
|---|---|---|
| 2023-12-31 | $35.81M 10-K · filed 2024-03-21 | |
| 2022-12-31 | $31.23M 10-K · filed 2024-03-21 | |
| 2021-12-31 | $27.26M 10-K · filed 2023-03-28 | $57.68M 10-K · filed 2022-03-17 |
| 2020-12-31 | $52.16M 10-K · filed 2022-03-17 | $56.03M 10-K · filed 2021-03-31 |
| 2019-12-31 | $53.22M 10-K · filed 2021-03-31 | |
| 2018-12-31 | $46.97M 10-K · filed 2020-03-30 | |
| 2017-12-31 | $40.87M 10-K · filed 2019-03-08 | |
| 2016-12-31 | $54.31M 10-K · filed 2018-03-14 | |
| 2015-12-31 | $49.51M 10-K · filed 2017-03-10 | |
| 2014-12-31 | $42.07M 10-K · filed 2016-03-11 | |
| 2013-12-31 | $35.57M 10-K · filed 2015-03-06 | |
| 2012-12-31 | $33.34M 10-K · filed 2014-03-17 | |
| 2011-12-31 | $33.78M 10-K · filed 2013-03-15 |